ATE286596T1 - Chemische modifikation von antikörpern und antigenen - Google Patents

Chemische modifikation von antikörpern und antigenen

Info

Publication number
ATE286596T1
ATE286596T1 AT95301020T AT95301020T ATE286596T1 AT E286596 T1 ATE286596 T1 AT E286596T1 AT 95301020 T AT95301020 T AT 95301020T AT 95301020 T AT95301020 T AT 95301020T AT E286596 T1 ATE286596 T1 AT E286596T1
Authority
AT
Austria
Prior art keywords
antigens
antibodies
chemical modification
chemically modified
modified antibodies
Prior art date
Application number
AT95301020T
Other languages
English (en)
Inventor
Adrian Charles Dawkes
John Arthur Diment
Graham Delisle Yearwood
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10750624&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE286596(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Application granted granted Critical
Publication of ATE286596T1 publication Critical patent/ATE286596T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
AT95301020T 1994-02-19 1995-02-17 Chemische modifikation von antikörpern und antigenen ATE286596T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9403215A GB9403215D0 (en) 1994-02-19 1994-02-19 Chemical modification of antibodies and antigens

Publications (1)

Publication Number Publication Date
ATE286596T1 true ATE286596T1 (de) 2005-01-15

Family

ID=10750624

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95301020T ATE286596T1 (de) 1994-02-19 1995-02-17 Chemische modifikation von antikörpern und antigenen

Country Status (6)

Country Link
US (1) US6197533B1 (de)
EP (1) EP0674175B1 (de)
JP (1) JPH0850132A (de)
AT (1) ATE286596T1 (de)
DE (1) DE69533904T2 (de)
GB (1) GB9403215D0 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9487823B2 (en) * 2002-12-20 2016-11-08 Qiagen Gmbh Nucleic acid amplification
US8043834B2 (en) * 2003-03-31 2011-10-25 Qiagen Gmbh Universal reagents for rolling circle amplification and methods of use
EP1863908B1 (de) * 2005-04-01 2010-11-17 Qiagen GmbH Reverse transkription und amplifikation von rna bei simultaner degradierung von dna
EP1762627A1 (de) 2005-09-09 2007-03-14 Qiagen GmbH Verfahren zur Aktivierung einer Nukleinsäure für eine Polymerase-Reaktion
DE102006020885A1 (de) * 2006-05-05 2007-11-08 Qiagen Gmbh Einführung von Sequenzelementen in Nukleinsäuren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914040A (en) * 1988-03-03 1990-04-03 Boehringer Mannheim Gmbh Reagent and method for determination of a polyvalent substance using an immunoaggregate
US5484706A (en) 1993-05-19 1996-01-16 Pasteur Sanofi Diagnostics Immunoassay for analytes in samples using alkylating agents

Also Published As

Publication number Publication date
EP0674175A3 (de) 1997-06-04
JPH0850132A (ja) 1996-02-20
GB9403215D0 (en) 1994-04-13
DE69533904T2 (de) 2005-12-01
EP0674175A2 (de) 1995-09-27
EP0674175B1 (de) 2005-01-05
US6197533B1 (en) 2001-03-06
DE69533904D1 (de) 2005-02-10

Similar Documents

Publication Publication Date Title
ATE278192T1 (de) Einfaches immunochemisches semiquantitatives bestimmungsverfahren und gerät
DE58902586D1 (de) Immunoassay und -rolymere igg-derivate zur kompensation von stoerfaktoren in immunoassays.
DE69833118D1 (de) Immunoassay zum bestimmen von bnp
DE69026615T2 (de) Igg3-antikörper mit verkürzter hinge-region und einem komplementaktivierungstest
ES2151528T3 (es) Composicion de calibrador o control para un ensayo de serologia igm.
ATE115729T1 (de) Testverfahren und reagenziensatz dafür.
ATE79678T1 (de) Bestimmung von monokinen.
DE59509344D1 (de) Antikörperklassenspezifisches entstörungsreagenz
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
ATE80466T1 (de) Verfahren und reagenz zur bestimmung eines reaktionspartners einer immunologischen reaktion.
ATE286596T1 (de) Chemische modifikation von antikörpern und antigenen
DE3686717T2 (de) Immuntestverfahren.
KR950703061A (ko) Fk506-결합 단백질을 인식하는 모노클로날 항체, fk506-결합 단백질의 농도를 분석하는 방법 및 이를 위한 키트(monoclonal antibody recognizing fk506-binding protein, method for assaying fk506-binding protein level, and kit therefor)
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
CA2123069A1 (en) Immunoassay for analytes in samples using alkylating agents
DE69526056T2 (de) Immunologisches Testverfahren zur Quantifizierung von PEG-modifiziertem humanem Granulozyten-Kolonie-Stimulierender-Faktor
ATE285075T1 (de) Detektion und quantifikation von vancomycin in den biologischen flüssigkeiten
ITMI930477A1 (it) Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio
DE68919521D1 (de) Immuntest zum Nachweis von alpha-Haloacetamiden.
EP0757250A4 (de) Verfahren zum testen eines asialoglycoproteinrezeptors und testreagenz dafür
DE3863270D1 (de) Immuntest.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties